(EQR) Equity Residential - Overview
Stock: Apartment Leasing, Property Management
| Risk 5d forecast | |
|---|---|
| Volatility | 20.9% |
| Relative Tail Risk | 2.69% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.46 |
| Alpha | -18.61 |
| Character TTM | |
|---|---|
| Beta | 0.646 |
| Beta Downside | 0.780 |
| Drawdowns 3y | |
|---|---|
| Max DD | 22.12% |
| CAGR/Max DD | 0.17 |
EPS (Earnings per Share)
Revenue
Description: EQR Equity Residential February 11, 2026
Equity Residential (NYSE:EQR) is a S&P 500-listed REIT that owns and manages 318 multifamily properties, totaling roughly 86,300 apartment units, primarily in high-density coastal metros with additional exposure to fast-growing markets such as Atlanta, Austin, Dallas/Ft. Worth, and Denver.
Recent performance metrics (Q4 2025):
• Occupancy ≈ 95.6 % (down 0.2 pp YoY, reflecting modest leasing pressure from rising mortgage rates).
• FY 2025 Funds From Operations (FFO) of $1.71 billion, yielding an FFO-per-share of $7.45, a 4 % increase versus FY 2024.
• Average rent growth of 3.1 % YoY, outpacing the national multifamily inflation rate of 2.4 % but lagging the 4 % growth observed in the Sun Belt cores.
Key drivers and risks:
– The sector is sensitive to the Federal Reserve’s policy stance; the current policy rate of 5.25 % keeps borrowing costs elevated, which can dampen new construction and support existing asset yields.
– Demographic trends (millennial and Gen-Z migration to urban and secondary-city hubs) continue to underpin demand, but a slowdown in net domestic migration could compress rent growth.
– Supply pipeline: approximately 12 % of EQR’s portfolio is slated for refurbishment or repositioning, which may boost unit-mix quality but also requires capital allocation amid higher financing spreads.
For a deeper quantitative dive into how these fundamentals translate into valuation expectations, a quick look at ValueRay’s model can help you benchmark EQR against peer REITs and assess scenario-based upside.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 1.12b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 0.19 > 1.0 |
| NWC/Revenue: -36.47% < 20% (prev -27.53%; Δ -8.94% < -1%) |
| CFO/TA 0.08 > 3% & CFO 1.65b > Net Income 1.12b |
| Net Debt (8.73b) to EBITDA (2.34b): 3.73 < 3 |
| Current Ratio: 0.05 > 1.5 & < 3 |
| Outstanding Shares: last quarter (388.7m) vs 12m ago -0.63% < -2% |
| Gross Margin: 46.32% > 18% (prev 0.63%; Δ 4568 % > 0.5%) |
| Asset Turnover: 14.92% > 50% (prev 14.30%; Δ 0.61% > 0%) |
| Interest Coverage Ratio: 4.28 > 6 (EBITDA TTM 2.34b / Interest Expense TTM 309.5m) |
Altman Z'' 0.39
| A: -0.05 (Total Current Assets 55.9m - Total Current Liabilities 1.19b) / Total Assets 20.75b |
| B: 0.06 (Retained Earnings 1.19b / Total Assets 20.75b) |
| C: 0.06 (EBIT TTM 1.32b / Avg Total Assets 20.79b) |
| D: 0.13 (Book Value of Equity 1.20b / Total Liabilities 9.34b) |
| Altman-Z'' Score: 0.39 = B |
Beneish M -2.76
| DSRI: 0.91 (Receivables 14.6m/15.5m, Revenue 3.10b/2.98b) |
| GMI: 1.37 (GM 46.32% / 63.27%) |
| AQI: 1.01 (AQ_t 0.98 / AQ_t-1 0.97) |
| SGI: 1.04 (Revenue 3.10b / 2.98b) |
| TATA: -0.03 (NI 1.12b - CFO 1.65b) / TA 20.75b) |
| Beneish M-Score: -2.76 (Cap -4..+1) = A |
What is the price of EQR shares?
Over the past week, the price has changed by -1.97%, over one month by +2.59%, over three months by +6.99% and over the past year by -8.93%.
Is EQR a buy, sell or hold?
- StrongBuy: 5
- Buy: 6
- Hold: 15
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the EQR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 70 | 11.8% |
| Analysts Target Price | 70 | 11.8% |
EQR Fundamental Data Overview February 21, 2026
P/E Forward = 44.843
P/S = 8.0202
P/B = 2.204
P/EG = 8.1454
Revenue TTM = 3.10b USD
EBIT TTM = 1.32b USD
EBITDA TTM = 2.34b USD
Long Term Debt = 7.59b USD (from longTermDebt, last quarter)
Short Term Debt = 1.19b USD (from shortTermDebt, last quarter)
Debt = 8.78b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.73b USD (from netDebt column, last quarter)
Enterprise Value = 33.54b USD (24.81b + Debt 8.78b - CCE 55.9m)
Interest Coverage Ratio = 4.28 (Ebit TTM 1.32b / Interest Expense TTM 309.5m)
EV/FCF = 26.01x (Enterprise Value 33.54b / FCF TTM 1.29b)
FCF Yield = 3.85% (FCF TTM 1.29b / Enterprise Value 33.54b)
FCF Margin = 41.59% (FCF TTM 1.29b / Revenue TTM 3.10b)
Net Margin = 36.12% (Net Income TTM 1.12b / Revenue TTM 3.10b)
Gross Margin = 46.32% ((Revenue TTM 3.10b - Cost of Revenue TTM 1.66b) / Revenue TTM)
Gross Margin QoQ = -1.80% (prev 63.38%)
Tobins Q-Ratio = 1.62 (Enterprise Value 33.54b / Total Assets 20.75b)
Interest Expense / Debt = 0.93% (Interest Expense 81.9m / Debt 8.78b)
Taxrate = 0.09% (361.0k / 391.9m)
NOPAT = 1.32b (EBIT 1.32b * (1 - 0.09%))
Current Ratio = 0.05 (Total Current Assets 55.9m / Total Current Liabilities 1.19b)
Debt / Equity = 0.80 (Debt 8.78b / totalStockholderEquity, last quarter 11.04b)
Debt / EBITDA = 3.73 (Net Debt 8.73b / EBITDA 2.34b)
Debt / FCF = 6.77 (Net Debt 8.73b / FCF TTM 1.29b)
Total Stockholder Equity = 11.05b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.39% (Net Income 1.12b / Total Assets 20.75b)
RoE = 10.14% (Net Income TTM 1.12b / Total Stockholder Equity 11.05b)
RoCE = 7.11% (EBIT 1.32b / Capital Employed (Equity 11.05b + L.T.Debt 7.59b))
RoIC = 6.88% (NOPAT 1.32b / Invested Capital 19.24b)
WACC = 6.37% (E(24.81b)/V(33.60b) * Re(8.30%) + D(8.78b)/V(33.60b) * Rd(0.93%) * (1-Tc(0.00)))
Discount Rate = 8.30% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.26%
[DCF Debug] Terminal Value 84.68% ; FCFF base≈1.28b ; Y1≈1.31b ; Y5≈1.46b
Fair Price DCF = 75.70 (EV 37.53b - Net Debt 8.73b = Equity 28.80b / Shares 380.5m; r=6.37% [WACC]; 5y FCF grow 2.60% → 2.90% )
EPS Correlation: -1.06 | EPS CAGR: 55.72% | SUE: 2.96 | # QB: 1
Revenue Correlation: 97.83 | Revenue CAGR: 5.16% | SUE: 0.37 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.28 | Chg30d=-0.034 | Revisions Net=+0 | Analysts=2
EPS current Year (2026-12-31): EPS=1.35 | Chg30d=-0.090 | Revisions Net=+0 | Growth EPS=+6.7% | Growth Revenue=+3.2%
EPS next Year (2027-12-31): EPS=1.52 | Chg30d=-0.055 | Revisions Net=+1 | Growth EPS=+13.0% | Growth Revenue=+3.6%